Fireside chat: AI’s emerging role in oligonucleotide development and manufacturing
Nucleic Acid Insights · 13.11.2026 · 3 (9) · 645–653
DOI: 10.18609/nai.2026.085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acid Insights, online erschienen am 13.11.2026. Verfasst von Srđan Maširević und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Artificial intelligence (AI) is discussed with increasing frequency across the nucleic acid therapeutics field: it is already productive in early molecular design and in data-rich analytical tasks, and considerably less mature in the steps that connect synthesis to final product quality. In this Fireside Chat, Nucleic Acid Insights convened Srđan Maširević (Computational Biologist and Machine Learning Scientist, A*STAR’s Genome Institute of Singapore) and Bao Zhong Cai (VP, CMC, GondolaBio) to discuss where AI and machine learning (ML) earn a place in oligonucleotide production today, the data and process foundations they depend on, and how far the field is from digital twins, real-time impurity characterization, and autonomous synthesis. This discussion was a spin-off from the Nucleic Acid Insights Special Interest Group held in April 2026 on enhancing the efficiency and sustainability of oligonucleotide manufacturing.
Zitieren
APA
Maširević, S., & Cai, B. Z. (2026). Fireside chat: AI’s emerging role in oligonucleotide development and manufacturing. Nucleic Acid Insights, 3(9), 645–653. https://doi.org/10.18609/nai.2026.085
Vancouver
Maširević S, Cai BZ. Fireside chat: AI’s emerging role in oligonucleotide development and manufacturing. Nucleic Acid Insights. 2026;3(9):645–653. doi:10.18609/nai.2026.085
BibTeX
@article{Mairevi2026,
author = {Maširević, Srđan and Cai, Bao Zhong},
title = {Fireside chat: AI’s emerging role in oligonucleotide development and manufacturing},
journal = {Nucleic Acid Insights},
year = {2026},
volume = {3},
number = {9},
pages = {645–653},
doi = {10.18609/nai.2026.085}
}
EUVIMED